5P01NS099114-05 |
2021 |
$133018 |
7850 |
Administrative Core |
DISNEY, MATTHEW D |
SCRIPPS FLORIDA |
5P01NS099114-05 |
2021 |
$175154 |
7851 |
Lead Optimization to Support Cellular and Animal Studies |
ROUSH, WILLIAM R |
SCRIPPS FLORIDA |
5P01NS099114-05 |
2021 |
$259425 |
7852 |
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms |
DISNEY, MATTHEW D |
SCRIPPS FLORIDA |
5P01NS099114-05 |
2021 |
$259424 |
7853 |
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development |
PETRUCELLI, LEONARD |
SCRIPPS FLORIDA |
5P01NS099114-05 |
2021 |
$259424 |
7854 |
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis |
ROTHSTEIN, JEFFREY D |
SCRIPPS FLORIDA |
5P01NS099114-04 |
2020 |
$133018 |
7850 |
Administrative Core |
DISNEY, MATTHEW D |
SCRIPPS FLORIDA |
5P01NS099114-04 |
2020 |
$175154 |
7851 |
Lead Optimization to Support Cellular and Animal Studies |
ROUSH, WILLIAM R |
SCRIPPS FLORIDA |
5P01NS099114-04 |
2020 |
$259425 |
7852 |
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms |
DISNEY, MATTHEW D |
SCRIPPS FLORIDA |
5P01NS099114-04 |
2020 |
$259424 |
7853 |
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development |
PETRUCELLI, LEONARD |
SCRIPPS FLORIDA |
5P01NS099114-04 |
2020 |
$259424 |
7854 |
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis |
ROTHSTEIN, JEFFREY D |
SCRIPPS FLORIDA |
5P01NS099114-03 |
2019 |
$163330 |
7850 |
Administrative Core |
DISNEY, MATTHEW D |
SCRIPPS FLORIDA |
5P01NS099114-03 |
2019 |
$225205 |
7851 |
Lead Optimization to Support Cellular and Animal Studies |
ROUSH, WILLIAM R |
SCRIPPS FLORIDA |
5P01NS099114-03 |
2019 |
$348955 |
7852 |
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms |
DISNEY, MATTHEW D |
SCRIPPS FLORIDA |
5P01NS099114-03 |
2019 |
$348955 |
7853 |
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development |
PETRUCELLI, LEONARD |
SCRIPPS FLORIDA |
5P01NS099114-03 |
2019 |
$348955 |
7854 |
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis |
ROTHSTEIN, JEFFREY D |
SCRIPPS FLORIDA |
5P01NS099114-02 |
2018 |
$348955 |
7854 |
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis |
ROTHSTEIN, JEFFREY D |
JOHNS HOPKINS UNIVERSITY |
5P01NS099114-02 |
2018 |
$348955 |
7853 |
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development |
PETRUCELLI, LEONARD |
MAYO CLINIC JACKSONVILLE |
5P01NS099114-02 |
2018 |
$163330 |
7850 |
Administrative Core |
DISNEY, MATTHEW D |
SCRIPPS RESEARCH INSTITUTE |
5P01NS099114-02 |
2018 |
$225205 |
7851 |
Lead Optimization to Support Cellular and Animal Studies |
ROUSH, WILLIAM R |
SCRIPPS RESEARCH INSTITUTE |
5P01NS099114-02 |
2018 |
$348955 |
7852 |
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms |
DISNEY, MATTHEW D |
SCRIPPS RESEARCH INSTITUTE |
1P01NS099114-01 |
2017 |
$296280 |
7854 |
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis |
ROTHSTEIN, JEFFREY D |
SCRIPPS RESEARCH INSTITUTE |
1P01NS099114-01 |
2017 |
$296280 |
7850 |
Administrative Core |
DISNEY, MATTHEW D |
SCRIPPS RESEARCH INSTITUTE |
1P01NS099114-01 |
2017 |
$296280 |
7852 |
Development of small molecule chemical probes to study r(G4C2)exp pathomechanisms |
DISNEY, MATTHEW D |
SCRIPPS RESEARCH INSTITUTE |
1P01NS099114-01 |
2017 |
$296280 |
7851 |
Lead Optimization to Support Cellular and Animal Studies |
ROUSH, WILLIAM R |
SCRIPPS RESEARCH INSTITUTE |
1P01NS099114-01 |
2017 |
$296280 |
7853 |
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker development |
PETRUCELLI, LEONARD |
MAYO CLINIC JACKSONVILLE |